Literature DB >> 1824340

Study of calcitonin and thyroglobulin gene expression in human mixed follicular and medullary thyroid carcinoma.

M Noel1, M C Delehaye, N Segond, F Lasmoles, B Caillou, P Gardet, P Fragu, M S Moukhtar.   

Abstract

mRNAs were isolated from 2 patients suffering from a familial form of a rare variant of medullary carcinoma of the thyroid (MTC), called mixed follicular and medullary carcinoma. The presence of calcitonin (CT) and thyroglobulin (Tg) mRNAs was checked by northern and in situ hybridization and compared with immunohistochemical results. In each case, mRNAs hybridizing to probes specific for CT and Tg were detected. Both proteins were quantified by radioimmunoassay determination in tissue extracts. Patient 1 had 20 ng Tg and 68 ng CT per micrograms total protein, and patient 2 had 0.4 ng Tg and 1.7 ng CT per micrograms total protein. Northern analysis showed that mixed carcinoma expressed several species of both CT mRNAs and Tg mRNAs. The main Tg transcripts present in neoplastic cells (8.5 and 4.8 kb for patient 1 and patient 2) were identical to or smaller than those of normal thyroid tissue (8.5 kb). The tumor CT mRNA (1 kb) was identical to that of normal tissue. In situ hybridization confirmed the presence of CT and Tg mRNA in the great majority of tumor cells. Furthermore, the presence of small amounts of organified iodine was evidenced by analytical ion microscopy in 35% of these cells. This raises an important question regarding the histogenesis of this tumor.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1824340     DOI: 10.1089/thy.1991.1.249

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  8 in total

1.  RET proto-oncogene mutation in a mixed medullary-follicular thyroid carcinoma.

Authors:  F Orlandi; E Chiefari; P Caraci; A Mussa; I Gonzatto; P De Giuli; D Giuffrida; A Angeli; S Filetti
Journal:  J Endocrinol Invest       Date:  2001-01       Impact factor: 4.256

2.  Mixed medullary and follicular carcinoma of the thyroid. On the search for its histogenesis.

Authors:  X Matias-Guiu
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

3.  Mixed medullary-follicular thyroid carcinoma. Molecular evidence for a dual origin of tumor components.

Authors:  M Volante; M Papotti; J Roth; P Saremaslani; E J Speel; R V Lloyd; J A Carney; P U Heitz; G Bussolati; P Komminoth
Journal:  Am J Pathol       Date:  1999-11       Impact factor: 4.307

4.  The Pathology of Medullary Carcinoma of the Thyroid: Review of the Literature and Personal Experience on 62 Cases.

Authors:  Mauro Papotti; Daniela Sambataro; Carla Pecchioni; Gianni Bussolati
Journal:  Endocr Pathol       Date:  1996       Impact factor: 3.943

Review 5.  Goblet cell carcinoids and other mixed neuroendocrine/nonneuroendocrine neoplasms.

Authors:  Marco Volante; Luisella Righi; Sofia Asioli; Gianni Bussolati; Mauro Papotti
Journal:  Virchows Arch       Date:  2007-08-08       Impact factor: 4.064

Review 6.  Pitfalls in Challenging Thyroid Tumors: Emphasis on Differential Diagnosis and Ancillary Biomarkers.

Authors:  José Manuel Cameselle-Teijeiro; Catarina Eloy; Manuel Sobrinho-Simões
Journal:  Endocr Pathol       Date:  2020-07-06       Impact factor: 3.943

7.  Mixed medullary-follicular carcinoma of the thyroid.

Authors:  Maasumeh Tohidi; Gholamreza Pourbehi; Mohammad Bahmanyar; Seyed Sajjad Eghbali; Mohammadreza Kalantar Hormozi; Iraj Nabipour
Journal:  Case Rep Endocrinol       Date:  2013-10-29

8.  Simultaneous medullary-papillary thyroid carcinoma.

Authors:  Faisal M H Al-Mashat
Journal:  Ann Saudi Med       Date:  2004 May-Jun       Impact factor: 1.526

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.